Duloxetine Hydrochloride is a dual serotonin and norepinephrine reuptake inhibitor (SNRI) that is used in the treatment of stress urinary incontinence, as well as depression. T., et al.: Neuropsychopharmacology, 8, 23 (1993), Fuller, R. Pharmacol., 40, 161 (2000) Duloxetine, a known dual serotonin and norepinephrine re-uptake inhibitor, has been reported to be commonly used for treatment of depression, diabetic neuropathic pain, fibromyalgia, anxiety, and urinary incontinence in women. Visit our website to find more information like suppliers, MSDS, infra-red (IR), nuclear magnetic resonance spectra (NMR), bp, mp, nd20, molecular formula (MF), molfile, sdf file, structure, 3d model. You will also find information like safety, risk, hazard and MSDS. This database is a catalog of over 1500000 chemicals and over 1000 chemical suppliers. If you are a supplier you may also add your own catalog of chemicals for free. Order ampicillin Buy zithromax per pill Amoxil chewable Duloxetine brand names Cymbalta, Yentreve, and in parts of Europe, Xeristar or Ariclaim is a drug which primarily targets major depressive disorder MDD. CYMBALTA is a selective serotonin and noradrenaline reuptake inhibitor. enteric-coated pellets of duloxetine hydrochloride equivalent to 30 mg or 60 mg of. Material Name Venlafaxine Hydrochloride Tablets. Trade Name EFFEXOR. Chemical Family Serotonin Noradrenaline Reuptake Inhibitor. Intended Use. Duloxetine Hydrochloride Capsules Duloxetine Hydrochloride Capsules Eli Lilly and Company Effective Date: 21-Sep-2005 Material Safety Data Sheet Section 1 - Chemical Product and Company Manufacturer's Emergency Phone: Manufacturer: 1-317-276-2000 Eli Lilly and Company CHEMTREC: Lilly Corporate Center 1-800-424-9300 (North America) Indianapolis, IN 46285 1-703-527-3887 (International) Common Name: Duloxetine Hydrochloride Capsules Chemical Name: 2-Thiophenepropanamine, N-methyl-gamma-(1-naphthalenyloxy)-, hydrochloride, (gamma S)- Synonym(s): 10% W/W duloxetine pellets; 20% W/W duloxetine pellets; 5% W/W duloxetine pellets; Duloxetine hydrochloride capsules, 20 mg; Duloxetine hydrochloride pulvules; Duloxetine hydrochloride pulvules, 30 mg; Duloxetine hydrochloride pulvules, 60 mg; Pulvules duloxetine hydrochloride; Encapsulated Duloxetine, 30 mg; Duloxetine pellets; Duloxetine hydrochloride pulvules, 40 mg; Duloxetine hydrochloride pulvules, 20 mg; Duloxetine hydrochloride pellets; Duloxetine hydrochloride; Duloxetine; Duloxetine capsule mix; 246916 formulation Trademarks(s): Cymbalta; Ari Claim; Yentreve Lilly Item Code(s): B02426; B02466; B02556; B02558; CK1079; CK1084; ND1068; ND1075; ND1078; ND1080; ND1109; PU3235; PU3236; PU3237; PU3240; PU3241; PU3242; PU3243; PU3244; PU3245; QA477P; QA511K; QD477P; UC5985; UC5986; UC5987; UC9542; UC9543; UC9544; UC9545; UC9564; UC9565; UC9566; UC9567; VF0344 See attached glossary for abbreviations. Section 2 - Composition / Information on Ingredients Ingredient CAS Concentration % Duloxetine Hydrochloride 136434-34-9 1.3 - 20 Excipients NA 80 - 98 Exposure Guidelines: Duloxetine hydrochloride - LEG 25 micrograms/m3 TWA for 12 hours. Excursion Limit 300 micrograms/m3 for no more than a total of 30 minutes. Caution Statement: Intact Duloxetine Hydrochloride Capsules are not considered to be a health hazard. Section 3 - Hazards Identification file://Z:\Legacy\EXTRACT 30NOV2006\MSDS_html\428117912/8/2006 Duloxetine Hydrochloride Capsules Appearance: Capsules containing pellets Physical State: Solid Odor: Odorless Emergency Overview Emergency Overview Effective Date: 17-Aug-2004 Lilly Laboratory Labeling Codes: Health 3 Fire 1 Reactivity 0 Primary Physical and Health Hazards: Not hazardous if intact. The contents of Duloxetine Hydrochloride Capsules may cause burns or permanent tissue damage to the eyes. Effects of exposure may include dizziness, nausea, drowsiness, fatigue, and liver effects. Effects of Overexposure: Capsules are intended for human consumption under guidance of a physician. Intact capsules are not considered hazardous under normal handling procedures. Adverse events commonly observed during therapeutic administration include nausea, dry mouth, constipation, decreased appetite, fatigue, dizziness, drowsiness, headache, insomnia, and increased sweating. Duloxetine, the active ingredient, is harmful if swallowed, may cause burns or permanent tissue damage to the eyes, and may be slightly irritating to the skin. Duloxetine Duloxetine (brand names Cymbalta, Yentreve, and in parts of Europe, Xeristar or Ariclaim) is a drug which primarily targets major depressive disorder (MDD), generalized anxiety disorder (GAD), pain related to diabetic peripheral neuropathy and in some countries stress urinary incontinence (SUI). It is manufactured and marketed by Eli Lilly and Company. Duloxetine has not yet been FDA approved for stress urinary incontinence or for fibromyalgia. Duloxetine is a selective SNRI (selective serotonin-norepinephrine reuptake inhibitor). Duloxetine is a systemic drug therapy which affects the body as a whole. Known also under the code name LY248686, it is a potent dual reuptake inhibitor of serotonin (5-hydroxytryptamine, 5-HT) and norepinephrine (NE), possessing comparable affinities in binding to NE- and 5-HT transporter sites. It is a less potent inhibitor of dopamine reuptake. Duloxetine hydrochloride msds Cymbalta duloxetine hydrochloride Capsules - FDA, Cymbalta - GuildLink Cheapest place to buy accutane Common Name Duloxetine Hydrochloride Capsules Chemical Name 2-Thiophenepropanamine, N-methyl-gamma-1-naphthalenyloxy-, hydrochloride. Duloxetine - MSDS. Material safety data sheet - Pfizer. Duloxetine hydrochloride Sigma-Aldrich. Apr 10, 2015. Product name, strength, pharmaceutical form Cymbalta 60 mg hard. duloxetine hydrochloride has pH dependent solubility with maximum. Revision Page 1 of 5. S-Duloxetine hydrochloride. SAFETY DATA SHEET. 11 /25/2014. Supersedes Revision according to Regulation EC No. 1907/2006. Duloxetine Hydrochloride USP. 136434-34-9. 20 mg, 30 mg and 60 mg. Fire and Explosion. Expected to be non-combustible. Health. The use of Monoamine.